Open Source Imaging Consortium (OSIC)OSIC – a global, 501(c)(3), not-for-profit cooperative effort between academia, industry and patient advocacy groups – was created to enable rapid, open source advances in the fight against idiopathic pulmonary fibrosis (IPF), fibrosing interstitial lung diseases (ILDs), and other respiratory diseases, including emphysematous conditions.
Our MissionOSIC brings together radiologists, clinicians, computational scientists, and industry competitors from around the world to advance digital imaging biomarkers for accurate imaging-based diagnosis, prognosis and prediction of response to therapy.
The partners work in pre-competitive areas for mutual benefit and, most importantly, the benefit of patients. |
|
A First‑of‑its‑Kind, Global Data Repository for Interstitial Lung DiseasesOSIC has launched its highly-anticipated, data repository of anonymized HRCT scans and clinical information regarding interstitial lung diseases (ILDs). This first-of-its-kind database is the world’s largest and most diverse, with a plethora of real world clinical and imaging data that is both multi-ethnic and multi-center. Driven by global experts in pulmonology, radiology and artificial intelligence, the repository currently houses close to 1,500 anonymized and quality-controlled scans with accompanying data, and has an additional 5,000 in the quality control queue. It is on track to reach its goal of 15,000 anonymized scans, available to OSIC members, by first quarter 2022.
|
OSIC: Driven by Leading Subject-matter ExpertsOSIC’s Core Science Leadership Team, a diverse group of leading experts responsible for driving progress toward the organization's goals, seeks to build a broad and diverse team of experts to tackle the challenges laid out by the OSIC.
|
|
Institutional Partners
These organizations have made multi-year commitments of funding and/or pledged to contribute with imaging and clinical data or with other means to OSIC to ensure that it is positioned for success.
